Back to search

Article

Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lung

2020-07-23

Abstract excerpt

<h4>Background</h4> Pseudomonas aeruginosa (P.a) infections are a major public health issue in ventilator-associated pneumoniae, cystic fibrosis and chronic obstructive pulmonary disease (COPD) exacerbations. This bacterium is multidrug resistant and there is an urgent need to develop new therapeutic approaches. <h4>Objective</h4> Evaluate the effect of direct pulmonary transplantation of gene-modified (elafin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
33608fa5-40ae-5771-8358-2ffc2013323e
DOI
10.1101/2020.07.22.214684
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Use of IL-6-elafin genetically modified regulatory macrophages as an immunotherapeutic against acute bacterial infection in the lungDOI 10.1101/2020.07.22.214684
Select a neighboring publication to make it the new centre.